Editorial & Institutional Desk

Aibotics Therapies, Inc. (AIBT): Late Filings Accumulate Amidst Business Shifts

By the PubCo Insight Editorial Desk, edited by Brad Listermann  ·  November 17, 2026
AIBT
AIBT Aibotics Therapies, Inc.

Aibotics Therapies, Inc. (AIBT) has once again informed the market of a delay in its financial reporting, marking another instance of an NT 10-Q filing. This pattern of non-timely submissions raises questions about the company's operational transparency and its ability to meet basic reporting obligations, which are fundamental for informed investment decisions.

AIBT price and volume
AIBT price and volume, last 90 days. Source: Yahoo Finance.

The most recent NT 10-Q, filed on November 16, 2026, signals a delay in the quarterly report. This follows a similar notice filed on August 14, 2026, for a prior quarter. While the company has filed some reports, the consistent use of non-timely notices suggests a recurring issue in its financial disclosure process. For investors, this creates a gap in understanding the current financial health and operational performance of AIBT, especially as the company has recently engaged in significant business activities.

Amidst these reporting delays, Aibotics Therapies has disclosed material business changes through various 8-K filings. An October 16, 2026, 8-K detailed a material agreement and an acquisition or disposition of assets. This was preceded by another 8-K on October 5, 2026, also reporting a material agreement. These corporate events, while potentially impactful, are difficult to fully assess without the accompanying financial context that timely 10-Q reports would provide.

The lack of current, audited financial statements means investors are operating with an incomplete picture. Without these details, it is challenging to evaluate the financial implications of the recent agreements and acquisitions, or to understand the company's cash position, debt load, and overall profitability. This situation can leave shareholders vulnerable, as critical information needed to assess risk and value is simply not available.

Investors in Aibotics Therapies, Inc. should be aware that repeated late filings can impact market perception and potentially lead to trading restrictions if the company falls out of compliance with exchange requirements. Keeping an eye on the company's filing status at PubCo Insight is a basic step for anyone considering or holding shares in AIBT.

Ultimately, investing in companies with a history of delinquent filings requires a clear understanding that the available information will likely be less comprehensive and less current than with fully compliant filers. Knowing what you own, in this case, means acknowledging the persistent information lag.

Primary sources (SEC EDGAR)

NT 10-Q 2026-11-16: https://www.sec.gov/Archives/edgar/data/1763329/000109690626001790/aibt_nt10q.htmSCHEDULE 13G 2026-10-29: https://www.sec.gov/Archives/edgar/data/1763329/000216236726000002/xslSCHEDULE_13G_X02/primary_doc.xml8-K 2026-10-16: https://www.sec.gov/Archives/edgar/data/1763329/000109690626001565/aibt-20261014_8k.htm8-K 2026-10-05: https://www.sec.gov/Archives/edgar/data/1763329/000109690626001500/aibt-20261002_8k.htm10-Q 2026-08-19: https://www.sec.gov/Archives/edgar/data/1763329/000109690626001264/tpia-20260630_10q.htmNT 10-Q 2026-08-14: https://www.sec.gov/Archives/edgar/data/1763329/000109690626001231/aibt_nt10q.htm
Compiled by the PubCo Insight Editorial & Institutional Desk from primary SEC EDGAR disclosures and market data. Published for informational and research purposes only, not investment advice or a buy/sell recommendation.
Investor relations · AIBT
Is this how AI describes Aibotics Therapies, Inc.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for AIBT: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent AIBT, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
See all AIBT filings and data  ·  Uplist Radar  ·  Catalyst Radar  ·  Pulse IR Capital & Institutional Desk